Obstructive Lung Disease

New Inhaler Drug for COPD Approved

WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, the agency announced.

A product of Novartis, the drug was tested in six clinical trials with a total of nearly 5,500 current or former smokers 40 and older.

An FDA advisory committee voted 13-4 in March to recommend that the drug be approved , although only at the 75-mcg dosage. The panel recommended against approval of a 150-mcg dose, citing a lack of clear evidence that the higher dose was any more effective or that it was as safe as the lower dose.

Following the committee's recommendation, the FDA approved only the 75-mcg dose.

This was the second try by Novartis to win FDA approval for indacaterol. The agency had rejected the company's first application in 2009, which had sought approval for doses as high as 300 mcg.

Novartis conducted additional clinical studies at the 75- and 150-mcg doses to satisfy the FDA's concerns.

The agency emphasized that the drug is not to be used to treat acute exacerbations. It also should not be used by people with asthma unless they are also taking long-term controller medications such as inhaled corticosteroids.

Indacaterol will carry the same black-box warning as other long-acting beta agonists about increased risk of asthma-related death.

Side effects seen most commonly in the drug's clinical studies included runny nose, cough, sore throat, headache, and nausea, the FDA said.

MedPage Today provides daily, peer-reviewed medical news articles, written specifically for the clinician.

Why register? While we cover most medical specialties, you can personalize the site to focus on your medical interests. Know before your patients ask. Have quick access to evidence-based data, when patients print out what they found online and may be from questionable sources. Optional breaking Medical News alerts. We NEVER sell, rent or otherwise share your personal data . Have the option to participate in occasional paid surveys. See article recommendations based on your specialty and declared interests. Earn quick CME or CE credit for reading the news. Available on most articles .

Obstructive Lung Disease - News


New Inhaler Drug for COPD Approved
New Inhaler Drug for COPD Approved

WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease,



Breathe your way to health
Breathe your way to health

Emphysema is an obstructive lung disease and occurs when lung tissue is damaged or destroyed. It is often caused by smoking. Medications and intelligent understanding of triggers can result in tremendous physical ability in order to benefit from an



No headway against COPD, which now affects women more
No headway against COPD, which now affects women more

WEDNESDAY, June 29 (HealthDay News) -- Between 1998 and 2009 there was no significant decline in cases of the often deadly ailment known as chronic obstructive pulmonary disease (COPD), and the burden of the disease has shifted from



COPD Prevalence Stable, but Death Rate Declines in Men
COPD Prevalence Stable, but Death Rate Declines in Men

June 29, 2011 -- Chronic obstructive pulmonary disease (COPD) remains a significant killer, according to a CDC report released today. The report, which tracks COPD statistics from 1998 until 2009, states that although the overall



Novartis' NVA237 Found Similar To Tiotropium In Improving Lung Function
Novartis' NVA237 Found Similar To Tiotropium In Improving Lung Function

Chronic obstructive pulmonary disease is a progressive, life-threatening disease associated with tobacco smoking, air pollution or occupational exposure. COPD affects 210 million people worldwide and is projected to be the third leading cause of death




COPD (Chronic Obstructive Pulmonary Disease) - New York NY ...

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.


Twitter

Eboko Dan COPD is a serious lung disease that makes breathing difficult. Symptoms can include breathlessness, chronic cough...


PharmQD COPD is a serious lung disease that makes breathing difficult. Symptoms can include breathlessness, chronic cough...


杉本 真優 Chronic Obstructive Pulmonary Disease Exacerbations (Lung Biology in Health and Disease):


Vernon Bianchi Selenium and Vitamin E reduced risk of chronic obstructive pulmonary disease (COPD) and increased lung function. thebestnaturalremedies.com


石黒 翼 Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease):


Obstructive Lung Disease - Bookshelf

Chronic Obstructive Lung Disease

Chronic Obstructive Lung Disease

This clinical reference for practitioners offers a new and comprehensive look at chronic obstructive lung disease.

Obstructive lung disease

Obstructive lung disease


Managing Chronic Obstructive Pulmonary Disease

Managing Chronic Obstructive Pulmonary Disease

Healthcare professionals from multi-disciplinary teams have contributed to this book to demonstrate that a co-ordinated approach for these patients is required ...

Obstructive lung disease

Obstructive lung disease


Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease

The only international clinical textbook in the Specialty, chronic Obstructive Pulmonary Disease is the first up-to-date reference source to include the latest ...

Daily News Directory


Obstructive lung disease - Wikipedia, the free encyclopedia
Obstructive lung disease is a category of respiratory disease ... Chronic obstructive pulmonary disease is mainly a combination of chronic bronchitis and emphysema, but may be ...

Chronic obstructive pulmonary disease - Wikipedia, the free ...
Gross pathology of a lung showing centrilobular-type emphysema ... Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), chronic ...

Restrictive vs. Obstructive Lung Disease
WebMD explains the difference between obstructive and restrictive lung disease, as well as symptoms, causes, and treatments.

Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is estimated to affect 32 million persons in the United States and is the fourth leading cause of death in this country.

Lung Diseases, Obstructive - Disease, Obstructive Lung ...
Lung Diseases, Obstructive. Definition: Any disorder marked by persistent obstruction of ... Synonym(s): Disease, Obstructive Lung / Diseases, Obstructive Lung / Lung Disease, ...